VITAMIN C AND E SUPPLEMENTATION VERSUS STANDARD MELOXICAM REGIMEN IN THE TREATMENT OF PATIENTS WITH CHRONIC DEGENERATIVE ARTHRITIS OF THE KNEE: A PRELIMINARY PILOT STUDY

Abstract

Objectives: To investigate the effectiveness of vitamin C and E supplementation in remission of the symptoms of chronic degenerative arthritis (osteoarthritis) of the knee. Design: A pilot controlled trial conducted from December 2009 until April 2011 among 46 patients diagnosed with osteoarthritis (OA) in one or both knees. Intervention: Patients were randomly assigned to two different treatment groups and were either supplemented with ascorbic acid 1 gr × 2 daily per os together with vitamin E 100 mg × 3 daily per os or they were treated with meloxicam tabs 15 mg × 1 daily per os. Main outcome measures: A. Clinical markers: functionality of the knee (WOMAC index), pain (using a pain visual analogue scale) and the deficit in knee flexion and extension B. Laboratory markers: total antioxidant capacity (TAC) and concentration of malonyldialdehyde (MDA) in the synovial fluid. Results: Twenty patients were randomly allocated into each of the two intervention groups. The treatment lasted for 20 days and the patients' status was evaluated every 10 days. The condition of the patients' knees in both treatment groups presented a significant improvement as recorded by the clinical markers; accompanied by an enhancement of TAC but with no effect on MDA levels. Conclusions: Administration of vitamins C and E has a similar effect in the remission of the symptoms of the OA in the knee, comparable to that of the treatment with meloxicam, but without the possible side effects and thus can be proposed as adjuvant therapy.